The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor's name and address for Akey, Inc.
DATES:
This rule is effective June 25, 2002.
FOR FURTHER INFORMATION CONTACT:
Lonnie W. Luther, Center for Veterinary Medicine (HFV-101), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301-827-0209, e-mail: lluther@cvm.fda.gov.
SUPPLEMENTARY INFORMATION:
Akey, Inc., P.O. Box 607, Lewisburg, OH 45338, has informed FDA of a change of name and address to North American Nutrition Companies, Inc., C.S. 5002, 6531 St., Rt. 503, Lewisburg, OH 45338. Accordingly, the agency is amending the regulations in 21 CFR 510.600(c) to reflect the change.
This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.
Therefore, under the Federal Food, Drug and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 510 is amended as follows:
PART 510—NEW ANIMAL DRUGS
1. The authority citation for 21 CFR part 510 continues to read as follows:
2. Section 510.600 is amended in the table in paragraph (c)(1) by removing the entry for “Akey, Inc.” and by alphabetically adding a new entry for “North American Nutrition Companies, Inc.”, and in the table in paragraph (c)(2) by revising the entry for “017790” to read as follows:
Use this for formal legal and research references to the published document.
67 FR 42717
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“New Animal Drugs; Change of Sponsor's Name and Address,” thefederalregister.org (June 25, 2002), https://thefederalregister.org/documents/02-15900/new-animal-drugs-change-of-sponsor-s-name-and-address.